Dual roles for immune metagenes in breast cancer prognosis and therapy prediction

BACKGROUND: Neoadjuvant chemotherapy for breast cancer leads to considerable variability in clinical responses, with only 10 to 20% of cases achieving complete pathologic responses (pCR). Biological and clinical factors that determine the extent of pCR are incompletely understood. Mounting evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Alistar, Angela, Chou, Jeff W, Nagalla, Srikanth, Black, Michael A, D’Agostino, Ralph, Miller, Lance D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240891/
https://www.ncbi.nlm.nih.gov/pubmed/25419236
http://dx.doi.org/10.1186/s13073-014-0080-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240891/
https://www.ncbi.nlm.nih.gov/pubmed/25419236
http://dx.doi.org/10.1186/s13073-014-0080-8

Ejemplares similares